News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
126,194 Results
Type
Article (8891)
Company Profile (19)
Press Release (117284)
Multimedia
Podcasts (8)
Webinars (3)
Section
Business (30125)
Career Advice (191)
Deals (3970)
Drug Delivery (18)
Drug Development (30833)
Employer Resources (23)
FDA (3780)
Job Trends (3444)
News (67815)
Policy (5899)
Tag
2024 BioForest Digital (1)
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (2)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (863)
Accelerated approval (1)
Adcomms (5)
Allergies (30)
Alliances (8528)
ALS (34)
Alzheimer's disease (605)
Antibody-drug conjugate (ADC) (13)
Approvals (3825)
Artificial intelligence (58)
Autoimmune disease (6)
Automation (1)
Bankruptcy (35)
Best Places to Work (3351)
Biosimilars (20)
Biotechnology (14)
Bladder cancer (13)
Brain cancer (5)
Breast cancer (85)
Cancer (633)
Cardiovascular disease (56)
Career advice (172)
Career pathing (7)
CAR-T (29)
Cell therapy (89)
Cervical cancer (6)
Clinical research (27490)
Collaboration (204)
Compensation (17)
Complete response letters (1)
COVID-19 (851)
CRISPR (14)
C-suite (56)
Cystic fibrosis (51)
Data (797)
Denatured (5)
Depression (11)
Diabetes (74)
Diagnostics (1121)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (8)
Drug discovery (30)
Drug pricing (8)
Drug shortages (2)
Duchenne muscular dystrophy (24)
Earnings (9856)
Editorial (8)
Employer branding (3)
Employer resources (23)
Events (15498)
Executive appointments (167)
FDA (4116)
Featured Employer (8)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (228)
Gene editing (25)
Generative AI (8)
Gene therapy (83)
GLP-1 (161)
Government (973)
Grass and pollen (1)
Guidances (7)
Healthcare (4320)
Huntington's disease (4)
IgA nephropathy (16)
Immunology and inflammation (29)
Indications (10)
Infectious disease (896)
Inflammatory bowel disease (46)
Inflation Reduction Act (2)
Influenza (15)
Intellectual property (17)
Interviews (21)
IPO (2064)
IRA (3)
Job creations (297)
Job search strategy (149)
Labor market (4)
Layoffs (61)
Leadership (4)
Legal (928)
Liver cancer (15)
Lung cancer (121)
Lymphoma (40)
Machine learning (2)
Management (4)
Manufacturing (45)
MASH (17)
Medical device (1781)
Medtech (1782)
Mergers & acquisitions (1981)
Metabolic disorders (174)
Multiple sclerosis (36)
NASH (6)
Neurodegenerative disease (28)
Neuropsychiatric disorders (3)
Neuroscience (817)
NextGen: Class of 2025 (1364)
Non-profit (3040)
Northern California (638)
Now hiring (1)
Obesity (88)
Opinion (50)
Ovarian cancer (31)
Pain (26)
Pancreatic cancer (17)
Parkinson's disease (83)
Partnered (4)
Patents (50)
Patient recruitment (34)
Peanut (25)
People (10197)
Pharmaceutical (7)
Phase I (6221)
Phase II (12012)
Phase III (10919)
Pipeline (307)
Policy (12)
Postmarket research (913)
Preclinical (1556)
Press Release (19)
Prostate cancer (33)
Psychedelics (7)
Radiopharmaceuticals (42)
Rare diseases (130)
Real estate (616)
Recruiting (9)
Regulatory (4608)
Reports (5)
Research institute (786)
Resumes & cover letters (22)
RSV (17)
Schizophrenia (24)
Series A (37)
Series B (21)
Sickle cell disease (17)
Southern California (451)
Special edition (1)
Spinal muscular atrophy (89)
Sponsored (7)
Startups (694)
State (1)
Stomach cancer (2)
Supply chain (7)
Tariffs (1)
The Weekly (3)
United States (4935)
Vaccines (188)
Venture capitalists (8)
Weight loss (45)
Women's health (3)
Worklife (3)
Date
Last 7 days (90)
Last 30 days (538)
Last 365 days (7743)
2025 (2244)
2024 (8135)
2023 (9256)
2022 (10749)
2021 (12367)
2020 (12497)
2019 (10394)
2018 (7834)
2017 (6376)
2016 (6418)
2015 (7066)
2014 (4843)
2013 (3385)
2012 (3539)
2011 (3761)
2010 (2956)
Location
Africa (177)
Alabama (7)
Alaska (4)
Arizona (21)
Arkansas (2)
Asia (7498)
Australia (1378)
California (1304)
Canada (356)
China (123)
Colorado (49)
Connecticut (84)
Delaware (49)
Europe (17948)
Florida (185)
Georgia (75)
Idaho (11)
Illinois (102)
India (6)
Indiana (119)
Iowa (2)
Japan (65)
Kansas (21)
Kentucky (10)
Louisiana (1)
Maine (4)
Maryland (176)
Massachusetts (920)
Michigan (36)
Minnesota (46)
Missouri (20)
Montana (12)
Nebraska (8)
Nevada (20)
New Hampshire (10)
New Jersey (498)
New Mexico (7)
New York (418)
North Carolina (155)
North Dakota (1)
Northern California (638)
Ohio (41)
Oklahoma (2)
Oregon (6)
Pennsylvania (279)
Rhode Island (6)
South America (181)
South Carolina (2)
South Dakota (1)
Southern California (451)
Tennessee (12)
Texas (185)
Utah (38)
Virginia (33)
Washington D.C. (20)
Washington State (115)
West Virginia (1)
Wisconsin (5)
126,194 Results for "foundation fighting blindness".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Opus Genetics Announces $1.7 Million in Project-based Funding from the Foundation Fighting Blindness to Support Two Preclinical Programs
Opus Genetics, a patient-first, clinical-stage gene therapy company developing treatments for inherited retinal diseases, announced it has received $1.7 million in project-based funding from the Foundation Fighting Blindness to help advance two preclinical candidate programs.
June 13, 2024
·
3 min read
Press Releases
Foundation Fighting Blindness and Usher III Initiative Partner to Launch a Natural History Study for Usher Syndrome Type 3
August 14, 2024
·
3 min read
BioCapital
Foundation Fighting Blindness to Host PRPH2 and Associated Retinal Diseases Workshop
The Foundation Fighting Blindness will host the free in-person PRPH2 and Associated Retinal Diseases Workshop on March 29–31, 2023, at the Hilton La Jolla Torrey Pines in San Diego, CA.
January 25, 2023
·
4 min read
Business
Foundation Fighting Blindness Announces Leadership Changes
The Foundation Fighting Blindness announced today the promotions of Jason Menzo to chief executive officer (CEO) of the Foundation and Russell Kelley, PhD, MBA, to managing director of the Retinal Degeneration (RD) Fund, the venture arm of the Foundation, effective July 1, 2022.
June 21, 2022
·
6 min read
Press Releases
How Doctor Came Up With Wound-Fighting Drug
March 24, 2025
·
1 min read
Machine Learning
Opinion: Smart Antibodies Will Transform Our Fight Against Solid Tumors
AI is enabling the development of a next generation of drugs that can more precisely target cancer cells while sparing healthy tissues.
April 14, 2025
·
4 min read
·
Gino Van Heeke
BioCapital
Verana Health Partners with Foundation Fighting Blindness to Integrate Genetic Testing Data into Real-World Evidence Research
Verana Health® announce a partnership focused on providing the life sciences community with deeper and broader data to optimize and expedite clinical trials.
November 2, 2023
·
5 min read
Venture capitalists
Tempero Raises $70M to Fight Substance Use Disorders
The company, launched with help from ex-Novartis executives, is targeting glutamate signaling in the brain to help treat alcohol- and cocaine-use disorders, among other indications.
March 24, 2025
·
1 min read
·
Dan Samorodnitsky
BioCapital
Diana Davis Spencer Foundation Pledges $5M to Foundation Fighting Blindness for Inherited Retinal Disease Research
The Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for blinding retinal diseases, has announced the launch of the Diana Davis Spencer Foundation.
January 27, 2022
·
2 min read
Press Releases
Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak
April 14, 2025
·
10 min read
1 of 12,620
Next
